The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2017
Filed:
Feb. 19, 2014
Applicant:
Lg Life Sciences Ltd., Seoul, KR;
Inventors:
Seung Yup Paek, Daejeon, KR;
Sung Bae Lee, Daejeon, KR;
Deok Seong Park, Daejeon, KR;
Won Hyung Lee, Daejeon, KR;
Assignee:
LG LIFE SCIENCES LTD., Seoul, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 271/12 (2006.01); C07D 413/04 (2006.01); A61K 31/4245 (2006.01); C07D 413/14 (2006.01); C07D 403/12 (2006.01); C07D 231/56 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01); C07D 209/08 (2006.01); C07D 209/30 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); C07D 209/08 (2013.01); C07D 209/30 (2013.01); C07D 231/56 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 413/04 (2013.01); C07D 471/04 (2013.01);
Abstract
The present invention relates to novel compounds of Formula 1 as sphingosine-1-phosphate receptor agonists which can be effectively used for the treatment of autoimmune diseases, a method for preparing the same, and a pharmaceutical composition comprising the same as an active component. The compounds according to the present invention are effective on extensive autoimmune diseases and chronic inflammatory diseases including relapsing-remitting multiple sclerosis, and can also be used for treating or preventing immunoregulation disorders.